Need for an incentive-based reimbursement policy toward quality care for dialysis patient management

Kidney International

Volumn 58, Issue 1, 2000, Pages 363-373

  Hidai, Hideo ^a  

^a Yokohama Dai ichi Hospital   (Japan)

Author keywords

CAPD; Dialysis cost; Erythropoietin; Hospital reimbursement; Japanese dialysis

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; DIALYSIS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; JAPAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; RESOURCE ALLOCATION; SURVIVAL RATE;

EID: 0033936338     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00174.x     Document Type: Article

References (54)

1. 1. KAHN JH, MACLEOD AM: Toward cost-effective dialysis therapy in Europe: The need for multidisciplinary approach. Nephrol Dial Transplant 12:2483-2485, 1997
2. 2. GAZE B: Resource allocation: The legal implications. J Contemp Health Law Policy 9:91-107, 1993
3. 3. JAPANESE SOCIETY FOR DIALYSIS THERAPY: An Overview of Regular Dialysis Treatment in Japan, as of December 31, 1998 (in Japanese). Tokyo, Japanese Society for Dialysis Therapy, 1999
4. 4. MINISTRY OF HEALTH AND WELFARE: National Medical Care Expenditure 1979-1996 (in Japanese). Tokyo, Welfare Statistics Association, 1981-1998
5. 5. MINISTRY OF HEALTH AND WELFARE: Report on Survey of Medical Care Activities in Public Health Insurance, Annual Report, June 1996 (in Japanese). Tokyo, Welfare Statistics Association, 1998
6. 6. MINISTRY OF HEALTH AND WELFARE: Revised point fee system for social insurance, 1967-1998 (in Japanese). Tokyo, Shakai-hoken Kenkyujo, 1967-98
7. 7. JAPANESE SOCIETY FOR DIALYSIS THERAPY: An overview of regular dialysis treatment in Japan 1973-1997 (in Japanese). Tokyo, Japanese Society for Dialysis Therapy, 1974-1998
8. 8. US RENAL DATA SYSTEM: USRDS 1995 Annual Data Report. IV. ESRD treatment modalities. Am J Kidney Dis 26(Suppl 2):S51-S68, 1995
9. 9. US RENAL DATA SYSTEM: USRDS 1996 Annual Data Report. IV. The USRDS dialysis morbidity and mortality study (wave 1). Am J Kidney Dis 28(Suppl 2):S58-S78, 1996
10. 10. US RENAL DATA SYSTEM: USRDS 1996 Annual Data Report. IX. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 28(Suppl 2):S127-S140, 1996
11. 11. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. II. Incidence and prevalence of ESRD patients. Am J Kidney Dis 32(Suppl 1):S38-S49, 1998
12. 12. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. III. Treatment modalities for ESRD patients. Am J Kidney Dis 32(Suppl 1):S50-S59, 1998
13. 13. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. IV. Medication use among dialysis patients in the DMMS. Am J Kidney Dis 32(Suppl 1):S60-S68, 1998
14. 14. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. V. Patient mortality and survival. Am J Kidney Dis 32(Suppl 1):S69-S80, 1998
15. 15. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. IX. Hospitalization Am J Kidney Dis 32(Suppl 1):S109-S117, 1998
16. 16. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. X. The economic cost of ESRD and Medicare spending for alternative modalities of treatment. Am J Kidney Dis 32(Suppl 1):S118-S131, 1998
17. 17. US RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. XII. International comparisons of ESRD therapy. Am J Kidney Dis 32(Suppl 1):S136-S141, 1998
18. 18. US RENAL DATA SYSTEM: USRDS 1999 Annual Data Report. IV. Patient characteristics at the start of ESRD: Data from the HCFA Medical Evidence Form. Am J Kidney Dis 34(Suppl 1):S63-S73, 1999
19. 19. BURTON B, DAY LM, PIERPOINT KL, VLCHECK DL: Can a global payment system work for the ESRD program? Nephrol News Issues 7:18-23, 1993
20. 20. WORLD HEALTH ORGANIZATION: Manual of the International Classification of Disease, Injuries and Causes of Death. Geneva, World Health Organization, 1977
21. 21. WORLD HEALTH ORGANIZATION: International Statistical Classification of Disease and Related Health Problems (10th revision). Geneva, World Health Organization, 1992
22. 22. JAPANESE SOCIETY FOR TRANSPLANTATION: Renal transplantation registry 1998. Jpn J Transplant 34:51-54, 1999
23. 23. UCHIDA H, TOMIKAWA S, WATANABE K: Renal transplantation vs. dialysis therapy, in Controversy Over Blood Purification, edited by AGISHI T, Tokyo, Kanehara Publishing, 1995, pp 7-15
24. 24. JAPANESE SOCIETY FOR DIALYSIS THERAPY: An Overview of Regular Dialysis Treatment in Japan as of December 31, 1989 (in Japanese). Tokyo, Japanese Society for Dialysis Therapy, 1990
25. 25. SAWANISHI K: Follow up on dialysis patients initiated below serum creatinine level 8.0 mg/dl. J Jpn Soc Dial Ther 23:I-X, 1990
26. 26. OLIVER AJ, IKEGAMI N, IKEDA S: Japan's aging population; Implication for health care. Pharmacoeconomics 11:306-318, 1997
27. 27. LIPPERT J, RITZ E, SCHWARZBECK A, SCHNEIDER P: The rising tide of end-stage renal failure from diabetic nephropathy type II: An epidemiological analysis. Nephrol Dial Transplant 10:462-467, 1995
28. 28. LAMEIRE N, JOFFE P, WIEDEMANN M: Health care systems: An international review: An overview. Nephrol Dial Transplant 14(Suppl 6):3-9, 1999
29. 29. JAPANESE ASSOCIATION OF KIDNEY DISEASE PATIENTS: Report on Survey of Hemodialysis Patients in Japan 1996 (in Japanese). Tokyo, Association for Periodicals by the Handicapped, 1997, p 104
30. 30. IGLEHART JK: Health policy report. II. Japan's medical care system. N Engl J Med 319:1166-1172, 1988
31. 31. AGISHI T, MINESHIMA N: Exponential increase of dialysis population. (editorial) J Jpn Soc Dial Ther 30:1159-1160, 1997
32. 32. HIDAI H, INOUE T: Ergonomics and medical economy in dialysis therapy. J Jpn Soc Dial Ther 28:937-956, 1995
33. 33. Japanese Diet: Organ Transplantation Act (in Japanese). July 16, 1997
34. 34. GOKAL R: Quality of life in patients undergoing renal replacement therapy. Kidney Int 43(Suppl 40):S23-S27, 1993
35. 35. LAUPACIS A, KEOWN P, PUS N, KRUEGER H, FERGUSON B, WONG C, MUIRHEAD N: A study of quality of life and cost-utility of renal transplantation. Kidney Int 50:235-242, 1996
36. 36. IGLEHART JK: Health policy report. I. Japan's medical care system. N Engl J Med 319:807-812, 1988
37. 37. IKEGAMI N, MITCHELL W, PENNER-HAHN J: Pharmaceutical prices, quantities and innovation: Comparing Japan with the US. Pharmacoeconomics 6:424-433, 1994
38. 38. Fox MP: Non-medical considerations in modality selection: Facility reimbursement: A critical comparison between hemodialysis and peritoneal dialysis. Am J Kidney Dis 22(Suppl 1):S32-S34, 1993
39. 39. SEOKA Y, YAMAGAMI S: Medical Economy in Home Therapy (in Japanese). Tokyo, Nippon Medical Center, 1997, pp 13-48
40. 40. JACOB C: The cost of dialysis treatment for patients with end-stage renal disease in France. Nephrol Dial Transplant 12(Suppl 1):29-32, 1997
41. 41. HELD PJ, WOLFE RA, GAYLIN DS, PORT FK, LEVIN NW, TURENNE MN: Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23:692-708, 1994
42. 42. FELDMAN HI, BILKER WB, HACKETT MH, SIMMONS CW, HOLMES JH, PAULY MV, ESCARCE JJ: Association of dialyzer reuse with hospitalization and survival rates among US hemodialysis patients: Do comorbidities matter? J Clin Epidemiol 50:209-217, 1999
43. 43. Japanese Diet: The Clinical Engineer Act. May 27, 1987
44. 44. RUSSEL MB, MANNING CL: The effect of prospective payment on Medicare expenditures. N Engl J Med 320:439-444, 1989
45. 45. HELD PJ, PORT EK, WEBB RL, TURENNE MN, WOLFE RA, HOLZMAN E, TEDESCHI P, HAKIM R, JONES CA, AGODA LYC: United States Renal Data System 1994, Annual data report. Am J Kidney Dis (Suppl 2):ss1-ss181, 1994
46. 46. FRIEDMAN EA: Death on hemodialysis: Preventable or inevitable? in Death on Hemodilaysis: Preventable or Inevitable? edited by FRIEDMAN EA, Dordrecht, Kluwer Academic, 1994, pp 1-11
47. 47. PRICE K: Dilemmas Facing Nephrology: "Dialysis Dead for Dollars, Patient Dead on Dialysis." San Francisco, 40th ASAIO Meeting, 1994
48. 48. BARTH RH: Short hemodialysis; big trouble in a small package, in Death on Hemodialysis; Preventable or Inevitable? edited by FRIEDMAN EA, Dordrecht, Kluwer Academic, 1994, pp 143-157
49. 49. MINISTRY OF HEALTH AND WELFARE: Report on Survey of Medical Care Activities in Public Health Insurance, Annual Report, June 1992 (in Japanese). Tokyo, Welfare Statistics Association, 1994
50. 50. NOSÉ Y: Why do we kill so many patients on hemodialysis in the US? (editorial) Artif Organs 17:893-894, 1993
51. 51. WONG JS, PORT FK, HULBERT-SHEARON TE, CARROL CE, WOLFE RA, AGODA LYC, DAUGIRDAS JT: Survival advantage in Asian-American end-stage renal disease patients. Kidney Int 55:2515-2523, 1999
52. 52. ABE MA: Hospital reimbursement schemes: Japan's point system and the United State's diagnosis related groups. Med Care 23:1055-1066, 1985
53. 53. HELD PJ, LEVIN NW, BOVBJERG RP, PAULY MV, DIAMOND LH: Mortality and duration of hemodialysis treatment. JAMA 265:861-875, 1991
54. 54. HIDAI H: Presidential Address; Merit and Demerit of 20th Century Dialysis Therapy. Yokohama, 43rd General Congress of the Japanese Society for Dialysis Therapy, May 30, 1998